BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12452889)

  • 1. Pyogenic granuloma-like lesions during capecitabine therapy.
    Piguet V; Borradori L
    Br J Dermatol; 2002 Dec; 147(6):1270-2. PubMed ID: 12452889
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyogenic granuloma-like lesions caused by capecitabine therapy.
    Piqué-Duran E; Pérez-Díaz MJ; Pérez-Cejudo JA
    Clin Exp Dermatol; 2008 Aug; 33(5):652-3. PubMed ID: 18616732
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blisters unlike others].
    Gugerli O; Leupin N
    Rev Med Suisse; 2006 Apr; 2(62):1076-7. PubMed ID: 16711153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hand-foot syndrome with capecitabine therapy].
    Marini A; Hengge UR
    Hautarzt; 2007 Jun; 58(6):532-6. PubMed ID: 16897045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
    Risum S; Langer SW
    Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute cutaneous lupus erythematosus induced by capecitabine.
    Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
    Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
    [No Abstract]   [Full Text] [Related]  

  • 7. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
    Tavares-Bello R
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867
    [No Abstract]   [Full Text] [Related]  

  • 8. Acral and palmo-plantar hyperpigmentation in a patient with disseminated hepatocellular carcinoma.
    Goyal R; Chalamalasetty SB; Madan K; Paul SB; Arora R; Safaya R; Acharya SK
    Indian J Gastroenterol; 2007; 26(6):292-3. PubMed ID: 18431015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxic dermatitis due to capecitabine: presentation of 2 cases and literature review].
    Gutiérrez-Pascual M; Sols-Candela M; Pinedo F; López-Estebaranz JL
    Actas Dermosifiliogr; 2009 May; 100(4):336-8. PubMed ID: 19463243
    [No Abstract]   [Full Text] [Related]  

  • 10. [Management of capecitabine-induced hand-foot syndrome by local phytotherapy].
    Kern E; Schmidinger M; Locker GJ; Kopp B
    Wien Med Wochenschr; 2007; 157(13-14):337-42. PubMed ID: 17704983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photosensitive lichenoid drug eruption to capecitabine.
    Walker G; Lane N; Parekh P
    J Am Acad Dermatol; 2014 Aug; 71(2):e52-3. PubMed ID: 25037814
    [No Abstract]   [Full Text] [Related]  

  • 12. [A woman with palmar and plantar hyperpigmentation].
    van Tienhoven G; Wilmink JW
    Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report.
    Lee SD; Kim HJ; Hwang SJ; Kim YJ; Nam SH; Kim BS
    Korean J Intern Med; 2007 Jun; 22(2):109-12. PubMed ID: 17616027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
    Villalón G; Martín JM; Pinazo MI; Calduch L; Alonso V; Jordá E
    Am J Clin Dermatol; 2009; 10(4):261-3. PubMed ID: 19489659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome?
    Do JE; Kim YC
    Clin Exp Dermatol; 2007 Sep; 32(5):519-21. PubMed ID: 17509060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer.
    Hague JS; Ilchyshyn A
    Clin Exp Dermatol; 2007 Jan; 32(1):102-3. PubMed ID: 16879449
    [No Abstract]   [Full Text] [Related]  

  • 17. A CDD polymorphism as predictor of capecitabine-induced hand-foot syndrome--letter.
    Ciccolini J; Evrard A; Lacarelle B
    Clin Cancer Res; 2012 Jan; 18(1):317. PubMed ID: 22215908
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyogenic granuloma possibly associated with capecitabine therapy.
    Fujiwara C; Motegi SI; Sekiguchi A; Amano H; Ishikawa O
    J Dermatol; 2017 Nov; 44(11):1329-1331. PubMed ID: 27864844
    [No Abstract]   [Full Text] [Related]  

  • 19. High frequency of hand foot syndrome with capecitabine.
    Kamil M; Haron M; Yosuff N; Khalid I; Azman N
    J Coll Physicians Surg Pak; 2010 Jun; 20(6):421-2. PubMed ID: 20642979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical henna for capecitabine induced hand-foot syndrome.
    Yucel I; Guzin G
    Invest New Drugs; 2008 Apr; 26(2):189-92. PubMed ID: 17885735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.